VYONDYS 53

SareptAssist Patient Guide: How to Get VYONDYS 53 at Low or No Cost

VYONDYS 53 (golodirsen) is an FDA-approved exon-skipping therapy for Duchenne muscular dystrophy (DMD) patients with a confirmed mutation amenable to exon 53 skipping. SareptAssist, from Sarepta Therapeutics, helps eligible U.S. patients access this treatment at low or no cost through patient assistance, co-pay support, and personalized case management, especially for uninsured or underinsured individuals.[1][2][6]

About VYONDYS 53

VYONDYS 53 treats certain boys with DMD, a rare genetic disorder causing progressive muscle weakness due to dystrophin gene mutations. Administered via intravenous infusion weekly, it aims to produce a shortened dystrophin protein to help muscle function. It's approved under accelerated approval based on increased dystrophin levels; ongoing studies verify clinical benefits. Common side effects include hypersensitivity reactions like hives or cough—seek immediate care if these occur. Always consult your doctor for full prescribing information.[5]

Who Qualifies for SareptAssist?

SareptAssist supports U.S. residents (including Puerto Rico) prescribed VYONDYS 53. Key eligibility:

• Uninsured or underinsured patients (no coverage required).[2][8]
• Needs-based for those unable to afford therapy.[2]
• Commercially insured patients may qualify for co-pay assistance to cover deductibles, co-pays, or co-insurance.[1][4]
• Must have an FDA-approved DMD diagnosis with exon 53 mutation.

Your dedicated Case Manager assesses eligibility, explores insurance benefits, and matches you to Sarepta or third-party financial aid programs.[1][4]

Income Eligibility Breakdown

Specific income thresholds aren't publicly detailed, as eligibility is needs-based and individualized. Case Managers review household income, assets, insurance status, and expenses. Here's a general overview based on similar programs:

Contact SareptAssist for your personalized assessment—eligibility isn't guaranteed.[1]

Insurance Requirements

• No insurance required for core patient assistance program (PAP), which provides free drug for qualifying uninsured/underinsured.[2][8]
• For co-pay program, must have commercial insurance (not Medicare/Medicaid).[1][3]
• Case Manager conducts benefits investigation to verify coverage, prior authorizations, or appeals.[1][4]
• If insured but 'rendered uninsured' (e.g., coverage denial), PAP may apply.[2][4]
• Patient may owe administration costs (e.g., infusion fees).[2]

Step-by-Step Application Process

1. Get Prescribed: Discuss VYONDYS 53 with your doctor, confirming exon 53 mutation via genetic testing.

2. Contact SareptAssist: Call 1-888-SAREPTA (1-888-727-3782), Mon-Fri 8:30am–6:30pm ET, or visit SareptAssist.com. Available for patients/caregivers.[1][4][6]

3. Complete START Form: Doctor fills out SareptAssist START Form (for exon-skipping therapies like VYONDYS 53). Download from SareptAssist.com.[6]

4. Submit Form: Fax to 1-800-621-5203 or email SareptAssist@Sarepta.com.[2][6]

5. Welcome Call: Case Manager contacts you to explain benefits, eligibility, and options.[1][4]

6. Enrollment: Sign consent for assistance program(s). Case Manager guides through co-pay or PAP enrollment.[1][2]

7. Approval & Start: Once approved, coordinate infusion (clinic or home).[1]

Spanish forms available.[6]

Timeline and Delivery

• Processing: Varies; benefits investigation starts immediately after START Form. Case Manager provides updates.[1][4]
• Approval: Typically days to weeks, depending on insurance/ docs.[2]
• Delivery: Intravenous infusion at approved centers or home via partners. Case Manager handles logistics.[1]
• Ongoing support: Periodic check-ins for refills/reauthorization.[1]

Alternatives if Denied

• Appeal Insurance Denial: Case Manager assists with prior authorization appeals.[1]
• Third-Party Charities: Info on groups like Assistance Fund for DMD.[2][4]
• Other Sarepta Programs: Co-pay if commercially insured.[1]
• Clinical Trials: Ask doctor about Sarepta trials.
• State Programs: Medicaid or local DMD resources via Parent Project Muscular Dystrophy.[10]

Reapply if circumstances change.

Disclaimer

This guide summarizes SareptAssist based on available info as of 2026. Eligibility, benefits, and terms can change—contact SareptAssist directly for latest details. Not medical/financial advice; consult your doctor/ advisor. Sarepta doesn't guarantee coverage. See full Prescribing Info for VYONDYS 53 risks.[1][5]